PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aethlon Medical Inc (AEMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00808Y3071
CUSIP00808Y307
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$5.30M
EPS (TTM)-$3.85
Gross Profit (TTM)-$354.91K
EBITDA (TTM)-$10.62M
Year Range$0.24 - $2.93
Target Price$3.86
Short %4.47%
Short Ratio0.69

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aethlon Medical Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aethlon Medical Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%AprilMayJuneJulyAugustSeptember
-100.00%
5.56%
AEMD (Aethlon Medical Inc)
Benchmark (^GSPC)

S&P 500

Returns By Period

Aethlon Medical Inc had a return of -84.12% year-to-date (YTD) and -87.12% in the last 12 months. Over the past 10 years, Aethlon Medical Inc had an annualized return of -54.63%, while the S&P 500 had an annualized return of 10.55%, indicating that Aethlon Medical Inc did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-84.12%13.39%
1 month18.67%4.02%
6 months-79.36%5.56%
1 year-87.12%21.51%
5 years (annualized)-62.44%12.69%
10 years (annualized)-54.63%10.55%

Monthly Returns

The table below presents the monthly returns of AEMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-16.89%-5.49%-2.33%-17.86%-68.33%14.12%-32.00%12.06%-84.12%
2023110.60%-16.09%-21.41%-0.18%-20.46%18.51%1.83%-24.97%-17.89%-35.78%31.03%15.26%-20.48%
2022-20.43%-10.81%10.61%-26.71%25.23%-16.42%-10.71%-3.00%-40.00%-16.15%-13.32%-34.89%-85.19%
2021-6.88%-4.35%-7.73%-10.34%-4.40%182.76%-0.41%-24.08%3.76%-6.99%-32.31%-23.46%-24.70%
2020350.67%-37.10%-44.32%-7.89%5.00%38.10%-4.43%-26.80%-4.93%-0.74%38.81%32.80%156.49%
2019-19.88%-26.32%-3.06%-20.01%-52.84%1.84%-39.73%33.50%-21.69%30.43%-35.56%-66.79%-96.13%
201832.74%0.67%-21.19%12.61%-6.72%2.40%-3.91%-21.13%21.64%-11.86%21.15%31.75%46.90%
20171.90%-11.92%-13.38%-31.71%-5.83%1.90%-4.67%-32.84%12.41%-36.24%4.90%9.71%-73.10%
2016-7.36%-23.53%11.43%-9.33%4.53%12.20%9.30%-17.01%-2.90%-5.18%-1.68%-10.26%-38.14%
2015-6.58%-23.97%19.47%-28.19%6.50%-25.00%53.46%-24.02%-5.67%6.70%-5.24%-6.22%-49.23%
20146.47%-6.08%12.35%9.95%-9.52%-4.74%-25.41%-7.41%-2.80%79.42%137.61%-48.36%57.35%
201315.50%11.39%24.89%-4.46%-5.81%3.13%32.35%18.52%3.12%-16.36%5.07%17.24%148.54%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AEMD is 7, indicating that it is in the bottom 7% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of AEMD is 77
AEMD (Aethlon Medical Inc)
The Sharpe Ratio Rank of AEMD is 1111Sharpe Ratio Rank
The Sortino Ratio Rank of AEMD is 66Sortino Ratio Rank
The Omega Ratio Rank of AEMD is 66Omega Ratio Rank
The Calmar Ratio Rank of AEMD is 44Calmar Ratio Rank
The Martin Ratio Rank of AEMD is 66Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Aethlon Medical Inc (AEMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AEMD
Sharpe ratio
The chart of Sharpe ratio for AEMD, currently valued at -0.77, compared to the broader market-4.00-2.000.002.00-0.77
Sortino ratio
The chart of Sortino ratio for AEMD, currently valued at -1.61, compared to the broader market-6.00-4.00-2.000.002.004.00-1.61
Omega ratio
The chart of Omega ratio for AEMD, currently valued at 0.79, compared to the broader market0.501.001.500.79
Calmar ratio
The chart of Calmar ratio for AEMD, currently valued at -0.87, compared to the broader market0.001.002.003.004.005.00-0.87
Martin ratio
The chart of Martin ratio for AEMD, currently valued at -1.54, compared to the broader market-5.000.005.0010.0015.0020.00-1.54
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.66, compared to the broader market-4.00-2.000.002.001.66
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.28, compared to the broader market-6.00-4.00-2.000.002.004.002.28
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.30, compared to the broader market0.501.001.501.30
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.49, compared to the broader market0.001.002.003.004.005.001.49
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.96, compared to the broader market-5.000.005.0010.0015.0020.007.96

Sharpe Ratio

The current Aethlon Medical Inc Sharpe ratio is -0.77. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Aethlon Medical Inc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AprilMayJuneJulyAugustSeptember
-0.77
1.66
AEMD (Aethlon Medical Inc)
Benchmark (^GSPC)

Dividends

Dividend History


Aethlon Medical Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-100.00%
-4.57%
AEMD (Aethlon Medical Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aethlon Medical Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aethlon Medical Inc was 100.00%, occurring on Aug 5, 2024. The portfolio has not yet recovered.

The current Aethlon Medical Inc drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%May 10, 20005590Aug 5, 2024
-22.22%Feb 25, 20001Feb 25, 20006Mar 31, 20007
-22.22%Apr 17, 20001Apr 17, 20001Apr 25, 20002
-20%Oct 8, 19992Oct 19, 19998Jan 10, 200010
-17.65%May 19, 19995Aug 11, 19991Sep 27, 19996

Volatility

Volatility Chart

The current Aethlon Medical Inc volatility is 54.50%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%AprilMayJuneJulyAugustSeptember
54.50%
4.88%
AEMD (Aethlon Medical Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aethlon Medical Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Aethlon Medical Inc.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items